12 Health Care Stocks Moving In Friday's After-Market Session
Protagenic Therapeutics Reprices Stock Options at Annual Meeting
Protagenic Therapeutics Shares Are Trading Higher After the Company Announced It Filed for an Offering of 5.84 Million Shares of Common Stock.
Express News | Protagenic Therapeutics Inc - on Nov 19, Co Receives Nasdaq Delist Determination Letter
10-Q: Q3 2024 Earnings Report
Protagenic Therapeutics Announces Pricing of Private Placement for Aggregate Gross Proceeds of $1.275 Million
Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
10-Q: Q2 2024 Earnings Report
Express News | Protagenic Therapeutics Inc Files for Mixed Shelf Offering of up to $100 Mln- SEC Filing
Jaguar Health, Altamira Therapeutics,Erasca Among Healthcare Movers
Protagenic Therapeutics pressure-regulating peptides showed excellent safety in the single-dose portion of the Phase I trial
Protagenic Therapeutics pressure-regulating peptides showed excellent safety in the single-dose portion of the Phase I trial
Express News | Protagenic Therapeutics Stress-Regulating Peptide Demonstrates Exceptional Safety in Single Dose Portion of Phase I Trial
Protagenic Therapeutics' Reports Safety Data From Single Dose Portion Of Phase 1 Trial Involving PT00114
Protagenic Therapeutics' Stress-Regulating Peptide Demonstrates Exceptional Safety in Single Dose Portion of Phase I Trial, Paving the Way for Next Steps Toward Potential Breakthrough Treatments in Stress Related Neuropsychiatric Disorders
10-Q: Q1 2024 Earnings Report
10-K/A: Annual report (Amendment)
Protagenic Therapeutics Completes Enrollment in Single Dose Portion of Phase 1 of Innovative Stress Disorder Trial
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Thursday's Intraday Session
KOPN, BTCM and CETX Among Mid-day Movers